Ocrelizumab Discontinuation After Recurrent Serious Infections in Clinically Stable Primary Progressive Multiple Sclerosis: A Case Report
Study Overview This case report explores the complexities surrounding the discontinuation of ocrelizumab, a monoclonal antibody used for treating primary […]
